{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:58:26Z","timestamp":1768003106935,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA142824"],"award-info":[{"award-number":["R01-CA142824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA142824"],"award-info":[{"award-number":["R01-CA142824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The prevalence of prostate cancer (PCa) necessitates advanced diagnostic approaches for detection and lesion characterization. Utilizing two patient cohorts (<jats:italic>n<\/jats:italic>\u2009=\u200985), this study analyzes a custom-designed 3D ultrasonic acoustic radiation force impulse (ARFI) elasticity imaging system alongside an Index of Suspicion (IOS) lesion ranking system to evaluate reader sensitivity, positive predictive values, inter-reader reliability, and ARFI-mpMRI concordance. The IOS system provides standardized criteria for lesion assessment, enabling consistency in stratifying PCa lesion suspicion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>Three readers were trained on multiparametric ultrasound (mpUS) (combined ARFI and B-mode) prostate image volumes from 6 patients based on the IOS criteria. The readers then marked suspicious lesions in 79 patients who were retrospectively compared with histopathology-identified (Cohort I, post-radical prostatectomy) or biopsy-confirmed (Cohort II) cancerous regions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The IOS criteria stratified lesions by Gleason grade (GG), with a higher IOS correlating with more aggressive lesions. mpUS imaging was more sensitive for detecting lesions with higher GG and preferentially identified lesions with lower MR apparent-diffusion coefficients and signs of extraprostatic extension. mpUS imaging demonstrated substantial inter-reader reliability and moderate overlap with mpMRI lesions, with increasing sensitivity to higher MRI PI-RADS score lesions. mpUS imaging was less sensitive than mpMRI to lesions with lower GG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The increased sensitivity of mpUS imaging to higher GG lesions and adverse histopathological factors, along with moderate agreement with mpMRI, suggest that mpUS has the potential to guide biopsy targeting of mpMRI-visible lesions or serve as an alternative biopsy-targeting approach when mpMRI is unavailable or clinically contraindicated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40644-025-00874-0","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:17:18Z","timestamp":1745410638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI"],"prefix":"10.1186","volume":"25","author":[{"given":"Spencer R.","family":"Moavenzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Deivasigamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinath","family":"Kotamarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Palmeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Polascik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn R.","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"6","key":"874_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"1","key":"874_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"Cancer J Clin"},{"key":"874_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA. A contemporary prostate Cancer grading system: A validated alternative to the Gleason score. Eur Urol. 2016;69:428\u201335.","journal-title":"Eur Urol"},{"key":"874_CR4","doi-asserted-by":"crossref","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S. Eur Urol. 2016;69:16\u201340. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.","DOI":"10.1016\/j.eururo.2015.08.052"},{"key":"874_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RC, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouviere O, Schoots IG, Wiegel T, Cornford P. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment Witsh curative intent. Eur Urol. 2017;71:618\u201329.","journal-title":"Eur Urol"},{"key":"874_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00345-015-1523-6","volume":"33","author":"A Postema","year":"2015","unstructured":"Postema A, Mischi M, de la Rosette J, Wijkstra H. Multiparametric ultrasound in the detection of prostate cancer: a systematic review. World J Urol. 2015;33:1651\u20139.","journal-title":"World J Urol"},{"issue":"11","key":"874_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.crad.2019.03.016","volume":"74","author":"CJ Das","year":"2019","unstructured":"Das CJ, Razik A, Sharma S, Verma S. Prostate biopsy: when and how to perform. Clin Radiol. 2019;74(11):853\u201364.","journal-title":"Clin Radiol"},{"key":"874_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2005.08.013","volume":"49","author":"AA Elabbady","year":"2006","unstructured":"Elabbady AA, Khedr MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol. 2006;49:49\u201353.","journal-title":"Eur Urol"},{"issue":"5","key":"874_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.clgc.2019.05.006","volume":"17","author":"X Tu","year":"2019","unstructured":"Tu X, Liu Z, Chang T, Qiu S, Xu H, Bao Y, Yang L, Wei Q, Zeng G. Transperineal magnetic resonance Imaging\u2013Targeted biopsy May perform better than transrectal route in the detection of clinically significant prostate cancer: systematic review and Meta-analysis. Clin Genitourin Cancer. 2019;17(5):860\u201370.","journal-title":"Clin Genitourin Cancer"},{"key":"874_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA. Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA - J Am Med Association. 2015;313:390\u20137.","journal-title":"JAMA - J Am Med Association"},{"key":"874_CR11","doi-asserted-by":"crossref","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Ol- droyd R, Parker C, Emberton M. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet, 2017;389:815\u2013822.","DOI":"10.1016\/S0140-6736(16)32401-1"},{"issue":"7","key":"874_CR12","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1007\/s00261-019-02391-8","volume":"45","author":"CJ Das","year":"2020","unstructured":"Das CJ, Razik A, Netaji A, Verma S. Prostate MRI-TRUS fusion biopsy: A review of the state of the Art procedure. Abdom Radiol. 2020;45(7):2176\u201383.","journal-title":"Abdom Radiol"},{"issue":"3","key":"874_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.21037\/tau.2017.01.02","volume":"6","author":"M Spektor","year":"2017","unstructured":"Spektor M, Mathur M, Weinreb JC. Standards for MRI reporting-the evolution to PI-RADS V 2.0. Transl Androl Urol. 2017;6(3):355\u201367.","journal-title":"Transl Androl Urol"},{"key":"874_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cct.2015.02.008","volume":"42","author":"A El-Shater Bosaily","year":"2015","unstructured":"El-Shater Bosaily A, Parker C, Brown LC, Gabe R, Hindley RG, Kaplan R, Emberton M, Ahmed HU, PROMIS Group. PROMIS\u2013Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer. Contemp Clin Trials. 2015;42:26\u201340.","journal-title":"Contemp Clin Trials"},{"key":"874_CR15","doi-asserted-by":"publisher","first-page":"20210509","DOI":"10.1259\/bjr.20210509","volume":"95","author":"CH Lee","year":"2022","unstructured":"Lee CH, Vellayappan B, Tan CH. Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis. Br J Radiol. 2022;95:20210509.","journal-title":"Br J Radiol"},{"issue":"2","key":"874_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/01617346241311901","volume":"47","author":"DY Chan","year":"2025","unstructured":"Chan DY, Moavenzadeh SR, Wightman WE, Palmeri ML, Polascik TJ, Nightingale KR. Clinical feasibility of 3-D acoustic radiation force impulse (ARFI) imaging for targeted prostate biopsy guidance. Ultrason Imaging. 2025;47(2):79\u201392.","journal-title":"Ultrason Imaging"},{"key":"874_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ultrasmedbio.2016.01.004","volume":"42","author":"ML Palmeri","year":"2016","unstructured":"Palmeri ML, Glass TJ, Miller ZA, Rosenzweig SJ, Buck A, Polascik TJ, Gupta RT, Brown AF, Madden J, Nightingale KR. Identifying clinically significant prostate cancers using 3-D in vivo acoustic radiation force impulse imaging with Whole-Mount histology validation. Ultrasound Med Biol. 2016;42:1251\u201362.","journal-title":"Ultrasound Med Biol"},{"issue":"12","key":"874_CR18","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.ultrasmedbio.2020.08.022","volume":"42","author":"DC Morris","year":"2020","unstructured":"Morris DC, Chan DY, Lye TH, Chen H, Palmeri ML, Polascik TJ, Foo W-C, Huang J, Mamou J, Nightingale KR. Multiparametric ultrasound for targeting prostate cancer: combining ARFI, SWEI, QUS and B-mode. Ultrasound Med Biol. 2020;42(12):3426\u201339.","journal-title":"Ultrasound Med Biol"},{"key":"874_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, Buatti J, Aylward S, Miller JV, Pieper S, Kikinis R. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30:1323\u201341.","journal-title":"Magn Reson Imaging"},{"key":"874_CR20","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.10819344","author":"S Moavenzadeh","year":"2024","unstructured":"Moavenzadeh S. spencer-moavenzadeh\/prostateReaderStudy: initial release (v1.0.0). Zenodo. 2024. https:\/\/doi.org\/10.5281\/zenodo.10819344","journal-title":"Zenodo"},{"issue":"8","key":"874_CR21","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1007\/s00261-019-02023-1","volume":"44","author":"AG Wibmer","year":"2019","unstructured":"Wibmer AG, Robertson NL, Hricak H, Zheng J, Capanu M, Stone S, Ehdaie B, Brawer MK, Vargas HA. Extracapsular extension on MRI indicates a more aggressive cell cycle progression genotype of prostate cancer. Abdom Radiol (NY). 2019;44(8):2864\u201373.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"874_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.prnil.2020.01.001","volume":"8","author":"F K\u0131z\u0131lay","year":"2020","unstructured":"K\u0131z\u0131lay F, \u00c7elik S, S\u00f6zen S, \u00d6zveren B, Eski\u00e7orap\u00e7\u0131 S, \u00d6zgen M, \u00d6zen H, Akdo\u011fan B, Aslan G, Narter F, \u00c7al \u00c7, T\u00fcrkeri L. Members of urooncology association. Correlation of Prostate-Imaging reporting and data scoring system scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Turkish prostate cancer patients: a multicenter study of the urooncology association. Prostate Int. 2020;8(1):10\u20135.","journal-title":"Prostate Int"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00874-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00874-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00874-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:17:20Z","timestamp":1745410640000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-025-00874-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00874-0","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"K. R. Nightingale and M. L. Palmeri have intellectual property related to radiation force-based imaging technologies that has been licensed to Siemens, Samsung, and MicroElastic Ultrasound Systems.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"55"}}